NEW YORK – 10x Genomics has countersued Bio-Rad Laboratories in a US District Court patent infringement suit.
Last week, 10x responded to Bio-Rad's allegations that 10x's Next GEM microfluidic chips infringe US Patent No. 10,190,115, "Methods and compositions for nucleic acid analysis" which covers the partitioning of a sample into droplets, in some cases.